AMY LONG: Open Payments
NPI 1518528785 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 25 payments from 13 companies in 2025. Trend: 2023 $97 · 2024 $68 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| INTUITIVE SURGICAL, INC. | 1 | $77 |
| Sumitomo Pharma America, Inc. | 5 | $72 |
| Lilly USA, LLC | 4 | $71 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
| IBSA Pharma Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Ossur Americas, Inc. | 1 | $18 |
Products named: Da Vinci Surgical System, GEMTESA, MOUNJARO, AREXVY, AIRSUPRA, Rybelsus, Tirosint, Kerendia.
Industry payments across AL — which companies pay providers there.
